Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Insmed Inc (INSM)  
$24.80 1.35 (5.16%) as of 4:30 Thu 4/18


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 151,572,000
Market Cap: 3.76(B)
Last Volume: 501,923 Avg Vol: 500,516
52 Week Range: $17.7 - $31.74
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Insmed is a biopharmaceutical company. Co.'s commercial product, ARIKAYCE, is approved in the U.S. for the treatment of Mycobacterium avium complex lung disease and in Europe for the treatment of nontuberculous mycobacterial lung infections. Co.'s pipelines include: brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis, cystic fibrosis and other neutrophil-mediated diseases; and treprostinil palmitil inhalation powder, an inhaled formulation of the treprostinil prodrug treprostinil palmitil for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 20,000 115,000
Total Buy Value $0 $0 $385,800 $2,053,450
Total People Bought 0 0 1 2
Total Buy Transactions 0 0 2 6
Total Shares Sold 0 281,112 346,399 721,644
Total Sell Value $0 $7,726,648 $8,958,863 $18,380,956
Total People Sold 0 7 7 7
Total Sell Transactions 0 22 45 68
End Date 2024-01-18 2023-10-17 2023-04-18 2022-04-18

   
Records found: 546
  Page 1 of 22  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Sharoky Melvin Md Director   –       •      –    2024-02-28 4 GA $0.00 $0 I/I 3,600 4,699     -
   Sharoky Melvin Md Director   –       •      –    2024-02-28 4 GD $0.00 $0 D/D 3,600 295,015     -
   Lewis William Chair and CEO   •       •      –    2024-02-28 4 OE $12.58 $629,000 I/I 50,000 50,500     -
   Flammer Martina M.d. Chief Medical Officer   •       –      –    2024-01-12 4 AS $28.63 $133,616 D/D (4,667) 106,898 -4%     
   Adsett Roger Chief Operating Officer   •       –      –    2024-01-12 4 AS $28.63 $150,336 D/D (5,251) 148,559 -4%     
   Flammer Martina M.d. Chief Medical Officer   •       –      –    2024-01-10 4 AS $28.90 $35,981 D/D (1,245) 111,565 -4%     
   Adsett Roger Chief Operating Officer   •       –      –    2024-01-10 4 AS $28.90 $102,190 D/D (3,536) 153,810 -4%     
   Bonstein Sara Chief Financial Officer   •       –      –    2024-01-09 4 S $29.18 $131,222 D/D (4,497) 114,051 15%     
   Flammer Martina M.d. Chief Medical Officer   •       –      –    2024-01-09 4 AS $29.01 $136,782 D/D (4,715) 112,810 -6%     
   Smith Michael Alexander General Counsel, Senior VP   •       –      –    2024-01-09 4 S $28.76 $68,247 D/D (2,373) 86,364 15%     
   Schaeffer Orlov S Nicole Chief People Strategy Officer   •       –      –    2024-01-09 4 AS $28.74 $105,831 D/D (3,668) 101,984 -6%     
   Schaeffer Orlov S Nicole Chief People Strategy Officer   •       –      –    2024-01-09 4 OE $20.49 $10,306 D/D 503 105,652     -
   Adsett Roger Chief Operating Officer   •       –      –    2024-01-09 4 AS $29.25 $112,232 D/D (3,837) 157,346 -6%     
   Wise John Drayton Chief Commercial Officer   •       –      –    2024-01-09 4 S $28.78 $53,560 D/D (1,861) 113,829 15%     
   Lewis William Chair and CEO   •       •      –    2024-01-09 4 AS $28.72 $283,955 D/D (9,887) 363,651 -6%     
   Lewis William Chair and CEO   •       •      –    2024-01-08 4 AS $29.11 $1,328,973 D/D (45,120) 373,538 -9%     
   Lewis William Chair and CEO   •       •      –    2024-01-08 4 OE $20.49 $924,509 D/D 45,120 393,707     -
   Flammer Martina M.d. Chief Medical Officer   •       –      –    2024-01-05 4 S $29.21 $40,478 D/D (1,386) 117,525 16%     
   Smith Michael Alexander General Counsel, Senior VP   •       –      –    2024-01-05 4 S $29.31 $18,374 D/D (627) 88,737 16%     
   Adsett Roger Chief Operating Officer   •       –      –    2024-01-05 4 S $29.21 $88,864 D/D (3,042) 161,183 16%     
   Lewis William Chair and CEO   •       •      –    2024-01-05 4 S $29.26 $204,195 D/D (6,979) 373,538 16%     
   Wise John Drayton Chief Commercial Officer   •       –      –    2024-01-05 4 AS $29.32 $34,216 D/D (1,167) 115,690 -7%     
   Schaeffer Orlov S Nicole Chief People Strategy Officer   •       –      –    2024-01-05 4 S $29.28 $42,661 D/D (1,457) 105,149 16%     
   Flammer Martina M.d. Chief Medical Officer   •       –      –    2024-01-04 4 A $0.00 $0 D/D 12,873 118,911     -
   Smith Michael Alexander General Counsel, Senior VP   •       –      –    2024-01-04 4 A $0.00 $0 D/D 11,800 89,364     -
  546 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 22
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us